Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $191.9 million.

  • Lifecore Biomedical, Inc. \De\'s Total Liabilities fell 407.33% to $191.9 million in Q2 2025 from the same period last year, while for May 2025 it was $191.9 million, marking a year-over-year decrease of 407.33%. This contributed to the annual value of $191.9 million for FY2025, which is 407.33% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Total Liabilities stood at $191.9 million, which was down 407.33% from $190.3 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Total Liabilities ranged from a high of $304.7 million in Q1 2021 and a low of $163.1 million during Q1 2023
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Total Liabilities had a median value of $201.8 million in 2023 and averaged $214.4 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Total Liabilities tumbled by 4036.48% in 2022 and then surged by 1689.69% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Total Liabilities (Quarter) stood at $265.9 million in 2021, then fell by 22.96% to $204.8 million in 2022, then dropped by 0.66% to $203.5 million in 2023, then fell by 3.86% to $195.6 million in 2024, then dropped by 1.9% to $191.9 million in 2025.
  • Its last three reported values are $191.9 million in Q2 2025, $190.3 million for Q1 2025, and $195.6 million during Q4 2024.